Literature DB >> 6603037

In vivo administration of Interleukin-2 enhances specific alloimmune responses.

S A Rosenberg, P J Spiess, S Schwarz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603037     DOI: 10.1097/00007890-198306000-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  10 in total

1.  Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.

Authors:  Y Zaloom; L P Walsh; P McCulloch; G Gallagher
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

2.  Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.

Authors:  P McCulloch; G Gallagher; L P Walsh; Y Zaloom; J Xie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

3.  The toxicity of recombinant human interleukin-2 in rats following intravenous infusion.

Authors:  Y L Matory; A E Chang; E H Lipford; R Braziel; C L Hyatt; S A Rosenberg
Journal:  J Natl Med Assoc       Date:  1987-05       Impact factor: 1.798

Review 4.  Lymphocyte proliferation, lymphokine production, and lymphocyte receptors in ageing and various clinical conditions.

Authors:  A L de Weck; F Kristensen; F Joncourt; F Bettens; C Walker; Y Wang
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Cloning, sequence, and expression of bovine interleukin 2.

Authors:  D P Cerretti; K McKereghan; A Larsen; M A Cantrell; D Anderson; S Gillis; D Cosman; P E Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Effect of T cell modulation on the translocation of bacteria from the gut and mesenteric lymph node.

Authors:  M A Maddaus; C L Wells; J L Platt; R M Condie; R L Simmons
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

7.  Recruitment of inflammatory cells to a tumor deposit potentiates the immunotherapeutic effects of interleukin-2.

Authors:  E P Steller; A M Eggermont; W Matthews; P H Sugarbaker
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Effect of interleukin-2 on the manifestation and growth of acetoxymethyl-methylnitrosamine-induced colorectal rat adenocarcinoma.

Authors:  F T Garzon; M Salas; M R Berger; H Kirchner
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

9.  Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness.

Authors:  H Kawamura; S A Rosenberg; J A Berzofsky
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

Authors:  S A Rosenberg; J J Mulé; P J Spiess; C M Reichert; S L Schwarz
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.